{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:14:41Z","timestamp":1784783681770,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric shock demands early vasoactive therapy to restore perfusion. When central access is delayed\u2014particularly in resource-limited settings\u2014peripheral vasopressors provide a feasible alternative. This systematic review and hierarchical Bayesian meta-analysis synthesized current evidence on peripheral vasopressor use in children, estimating incidence, characteristics, and probabilistic risk of local complications to inform safe clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We systematically searched PubMed\/MEDLINE, EMBASE, LILACS, Google Scholar, and the Cochrane Library (January 1990\u2013March 2025) using MeSH and free-text terms for vasoactive agents, peripheral intravenous access, pediatric populations, and adverse events. Studies including children aged 1 month\u201318 years who received peripheral vasopressors and reported local complications were eligible. Two reviewers independently extracted data and assessed study quality using the Joanna Briggs Institute (JBI) checklist. The primary outcome was the pooled proportion of local adverse events. Frequentist and hierarchical Bayesian logistic models estimated pooled rates, 95% confidence or credible intervals, and predictive uncertainty. Weakly informative priors {half-Cauchy for random effects, normal [(0,1)] for log-odds} were applied, and posterior estimates derived via Markov Chain Monte Carlo (four chains, 2,000 iterations,\n                      <jats:italic>R^<\/jats:italic>\n                      \u2009&amp;lt;\u20091.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven studies comprising 1,575 pediatric patients were included. The pooled incidence of local adverse events was 1.97% (95% CI, 1.41\u20132.82) with no severe complications such as necrosis, ischemia, or need for surgery. The Bayesian model yielded a consistent pooled rate of 1.8% (CrI95%, 1.0\u20132.8), with a 68% probability of being below 2% and 99% below 3%. Predictive intervals suggested new studies of 100\u2013300 patients would show rates between 0% and 5%, confirming reproducibility. Subgroup analyses revealed no meaningful differences by setting or catecholamine type. Most events were mild extravasations after a median infusion of 4.1\u2005h (IQR, 2.9\u20137.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Peripheral vasopressor administration in pediatric shock is associated with a very low incidence of local adverse events. The Bayesian hierarchical model confirmed these findings with high probabilistic confidence, supporting peripheral administration as a safe and rapid approach for early hemodynamic stabilization. Peripheral vasopressors may be used for short durations (typically &amp;lt;4\u2005h, according to the included studies) while central access is being established, thereby minimizing delays in critical resuscitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251115788<\/jats:ext-link>\n                      , identifier CRD420251115788.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1719260","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:31:43Z","timestamp":1763706703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Adverse events and predictive probability of peripheral vasopressor administration in pediatric shock: integrating frequentist and hierarchical Bayesian meta-analyses"],"prefix":"10.3389","volume":"13","author":[{"given":"Mario","family":"Martinez-Solarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Fern\u00e1ndez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fern\u00e1ndez-Sarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Guti\u00e9rrez-Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Sarmiento-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Mulett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carolina Fern\u00e1ndez-Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Copana-Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Casson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhi","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Guayambuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Girishkumar Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"653e9","DOI":"10.1016\/j.jcrc.2015.01.014","article-title":"A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters","volume":"30","author":"Loubani","year":"2015","journal-title":"J Crit Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13054-021-03553-1","article-title":"Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis","volume":"25","author":"Owen","year":"2021","journal-title":"Crit Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1542\/peds.2015-1507","article-title":"Complications of central venous access devices: a systematic review","volume":"136","author":"Ullman","year":"2015","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc13868","article-title":"Timing of vasopressor initiation and mortality in septic shock: a cohort study","volume":"18","author":"Beck","year":"2014","journal-title":"Crit Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6160563","DOI":"10.1155\/2022\/6160563","article-title":"Safety of vasopressor medications through peripheral line in pediatric patients in PICU in a resource-limited setting","volume":"2022","author":"Abrar","year":"2022","journal-title":"Crit Care Res Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e12395","DOI":"10.1002\/emp2.12395","article-title":"Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children","volume":"2","author":"Charbel","year":"2021","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1097\/PEC.0000000000002295","article-title":"Use of inotropics by peripheral vascular line in the first hour of treatment of pediatric septic shock: experience at an emergency department","volume":"38","author":"Kohn-Loncarica","year":"2022","journal-title":"Pediatr Emerg Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7199\/ped.oncall.2015.35","article-title":"Study of vasoactive infusions through peripheral line","volume":"12","author":"Kumar","year":"2015","journal-title":"Pediatr Oncall J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1111\/j.1651-2227.2012.02725.x","article-title":"Noradrenaline use for septic shock in children: doses, routes of administration and complications","volume":"101","author":"Lampin","year":"2012","journal-title":"Acta Paediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/PCC.0000000000002970","article-title":"Peripheral vasoactive administration in critically ill children with shock: a single-center retrospective cohort study","volume":"23","author":"Levy","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2333794X211022250","DOI":"10.1177\/2333794X211022250","article-title":"Peripheral inotropes in critically ill children: is it safe?","volume":"8","author":"Mooli","year":"2021","journal-title":"Glob Pediatr Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.NAJ.0000282299.03441.c7","article-title":"Infiltration and extravasation","volume":"107","author":"Hadaway","year":"2007","journal-title":"Am J Nurs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1097\/PCC.0000000000003714","article-title":"Sepsis in critically ill children in Bolivia: multicenter retrospective evaluation of the Phoenix criteria for sepsis in a 2023 cohort","volume":"26","author":"Copana-Olmos","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1097\/PCC.0000000000001230","article-title":"Short-Term peripheral vasoactive infusions in pediatrics: where is the harm?","volume":"18","author":"Patregnani","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/PCC.0000000000002972","article-title":"Peripheral and central\/intraosseous vasoactive infusions during and after pediatric critical care transport: retrospective cohort study of extravasation injury","volume":"23","author":"Peshimam","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16340","DOI":"10.1038\/s41598-022-20510-2","article-title":"Safety and outcomes of short-term use of peripheral vasoactive infusions in critically ill paediatric population in the emergency department","volume":"12","author":"Yeong","year":"2022","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/PEC.0b013e3181ea71e1","article-title":"The use of vasoactive agents via peripheral intravenous access during transport of critically III infants and children","volume":"26","author":"Turner","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1742-6723.13394","article-title":"Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study","volume":"32","author":"Delaney","year":"2020","journal-title":"Emerg Med Australas"},{"key":"B22","first-page":"1","article-title":"Survey on the use of peripheral noradrenaline infusions within paediatric critical care patients in the United Kingdom","volume":"5","author":"Diviney","year":"2024","journal-title":"J London.Paeds"},{"key":"B23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/PCC.0000000000003351","article-title":"Resuscitation in paediatric sepsis randomized controlled pilot platform study in the emergency department (RESPOND ED) study group. Resuscitation with early Adrenaline infusion for children with septic shock: a randomized pilot trial","volume":"25","author":"Harley","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1097\/PEC.0000000000001838","article-title":"How are clinicians treating children with sepsis in emergency departments in Latin America? An international multicenter survey","volume":"37","author":"Kohn-Loncarica","year":"2021","journal-title":"Pediatr Emerg Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1053\/j.jvca.2024.08.020","article-title":"Local adverse events associated with peripheral vasoactive infusion in children: a systematic review with meta-analysis","volume":"38","author":"Takeshita","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1177\/08850666211054444","article-title":"Latin American Consensus on the management of sepsis in children: sociedad latinoamericana de cuidados intensivos pedi\u00e1tricos [Latin American pediatric intensive care society] (SLACIP) task force: executive summary","volume":"37","author":"Fern\u00e1ndez-Sarmiento","year":"2022","journal-title":"J Intensive Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.11124\/JBIES-23-00430","article-title":"Bayesian Approach for meta-analyses in biomedical research: a scoping review protocol","volume":"22","author":"Santos","year":"2024","journal-title":"JBI Evid Synth"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.3390\/ijerph18073492","article-title":"Bayesian Methods for meta-analyses of binary outcomes: implementations, examples, and impact of priors","volume":"18","author":"Al Amer","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41562-021-01177-7","article-title":"Bayesian Analysis reporting guidelines","volume":"5","author":"Kruschke","year":"2021","journal-title":"Nat Hum Behav"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.2024.7741","article-title":"Causal inference about the effects of interventions from observational studies in medical journals","volume":"331","author":"Dahabreh","year":"2024","journal-title":"JAMA"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1719260\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:31:44Z","timestamp":1763706704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1719260\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":30,"alternative-id":["10.3389\/fped.2025.1719260"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1719260","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1719260"}}